Savitha M. Rao

Array ( [id] => 5348777 [patent_doc_number] => 20090004138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Bicyclic Nucleosides and Nucleotides as Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 11/908019 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15544 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004138.pdf [firstpage_image] =>[orig_patent_app_number] => 11908019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258802 [patent_doc_number] => 20070212434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Compositions and methods for human use containing fulvic acid' [patent_app_type] => utility [patent_app_number] => 11/369655 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8396 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212434.pdf [firstpage_image] =>[orig_patent_app_number] => 11369655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733582 [patent_doc_number] => 20060258699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Compounds for inhibiting KSP kinesin activity' [patent_app_type] => utility [patent_app_number] => 11/370005 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10328 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258699.pdf [firstpage_image] =>[orig_patent_app_number] => 11370005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608085 [patent_doc_number] => 20060269601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support' [patent_app_type] => utility [patent_app_number] => 11/366947 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3604 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269601.pdf [firstpage_image] =>[orig_patent_app_number] => 11366947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522050 [patent_doc_number] => 20090030031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Method of Preferentially Inducing the Biosynthesis of Interferon' [patent_app_type] => utility [patent_app_number] => 11/884982 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 55160 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030031.pdf [firstpage_image] =>[orig_patent_app_number] => 11884982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657404 [patent_doc_number] => 20110306673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'CRYSTALLINE FORMS OF (1RS,2RS,6RS)-6-DIMETHYLAMINOMETHYL-1-(3-METHOXYPHENYL)CYCLOHEXANE-1,3-DIOL HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 11/885039 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6386 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306673.pdf [firstpage_image] =>[orig_patent_app_number] => 11885039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786336 [patent_doc_number] => 20080139665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Androgen Receptor-Dependent Gene Expression Control' [patent_app_type] => utility [patent_app_number] => 11/884568 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6291 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139665.pdf [firstpage_image] =>[orig_patent_app_number] => 11884568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965879 [patent_doc_number] => 20080108699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Composition Comprising Dihomo-y-Linolenic Acid (Dgla) As Active Ingredient' [patent_app_type] => utility [patent_app_number] => 11/884199 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11697 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108699.pdf [firstpage_image] =>[orig_patent_app_number] => 11884199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880503 [patent_doc_number] => 20080153886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Use Of Heterocyclic Compounds As Neurogenic Agents' [patent_app_type] => utility [patent_app_number] => 11/815856 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6160 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153886.pdf [firstpage_image] =>[orig_patent_app_number] => 11815856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779548 [patent_doc_number] => 20080287546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Quorum Sensing Modulators' [patent_app_type] => utility [patent_app_number] => 11/795621 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6386 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287546.pdf [firstpage_image] =>[orig_patent_app_number] => 11795621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188078 [patent_doc_number] => 20070166386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Nanoparticle formation of pharmaceutical ingredients' [patent_app_type] => utility [patent_app_number] => 11/332131 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4504 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166386.pdf [firstpage_image] =>[orig_patent_app_number] => 11332131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214456 [patent_doc_number] => 08193245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Composition comprising oleic acid and the use thereof' [patent_app_type] => utility [patent_app_number] => 12/064134 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3310 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193245.pdf [firstpage_image] =>[orig_patent_app_number] => 12064134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904644 [patent_doc_number] => 20080114058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use Of Lignan Compounds For Treating Or Preventing Inflammatory Disease' [patent_app_type] => utility [patent_app_number] => 11/813590 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114058.pdf [firstpage_image] =>[orig_patent_app_number] => 11813590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658233 [patent_doc_number] => 20080027095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 11/794400 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7789 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027095.pdf [firstpage_image] =>[orig_patent_app_number] => 11794400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142425 [patent_doc_number] => 20070004641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate' [patent_app_type] => utility [patent_app_number] => 11/315784 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15739 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004641.pdf [firstpage_image] =>[orig_patent_app_number] => 11315784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375889 [patent_doc_number] => 08680154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Injectable veterinary composition' [patent_app_type] => utility [patent_app_number] => 11/722280 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3459 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11722280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652186 [patent_doc_number] => 20080039442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Compounds With Kv4 Ion Channel Activity' [patent_app_type] => utility [patent_app_number] => 11/793559 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30575 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039442.pdf [firstpage_image] =>[orig_patent_app_number] => 11793559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989340 [patent_doc_number] => 20070155681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Methods and compositions for treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 11/298629 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24201 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155681.pdf [firstpage_image] =>[orig_patent_app_number] => 11298629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236140 [patent_doc_number] => 20070128297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Apparatus and method for treatment of nasal congestion' [patent_app_type] => utility [patent_app_number] => 11/295946 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2199 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128297.pdf [firstpage_image] =>[orig_patent_app_number] => 11295946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10064066 [patent_doc_number] => 09102899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 11/720996 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3231 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11720996 [rel_patent_id] =>[rel_patent_doc_number] =>)